SARS-CoV-2 Infections among Vaccinated Patients on Maintenance Dialysis, January 1-August 31, 2021, United States

Kidney360. 2022 Sep 16;3(11):1934-1938. doi: 10.34067/KID.0003092022. eCollection 2022 Nov 24.

Abstract

Dialysis facilities voluntarily reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in vaccinated dialysis patients detected between January 1, 2021, and August 31, 2021, to the Centers for Disease Control and Prevention.Among 4087 patients reported, most were symptomatic, a third required hospitalization, and 9% died within 30 days of diagnosis.Monitoring SARS-CoV-2 infections and outcomes among vaccinated people on dialysis provides valuable insight into this population.

Keywords: COVID-19; COVID-19 vaccine; ESKD; SARS-CoV-2; United States; dialysis; end stage renal disease.

MeSH terms

  • COVID-19* / epidemiology
  • Centers for Disease Control and Prevention, U.S.
  • Humans
  • Patients
  • Renal Dialysis / adverse effects
  • SARS-CoV-2
  • United States / epidemiology